About our foundational clinical study:

The Contino® urethral insert in the treatment of male stress urinary incontinence

The five-year multi-site clinical study demonstrated safety and efficacy of improved management of stress urinary incontinence (UI) in men. Study participants experienced a significant reduction in absorbent pad weight and improved quality of life. Some participants also observed health improvements related to both urinary function and general health including improved urge reflex and bladder sensitivity. It is also important to note that there were no serious adverse events (AE) and of the AEs reported, almost all were minor and expected, with minor medical intervention required on only three occasions.

Read the Contino® clinical study

Read our foundational clinical study for Contino® in the June 2020 edition of the Canadian Urology Association Journal (CUAJ).


(Starting on Page 39)

Join a Contino® clinical trial

We are now enrolling male volunteers with stress urinary incontinence (leaking urine with activity, or coughing/ sneezing) to participate in a post-market clinical follow-up study for the Contino® device. To learn more.

Contact Us